Global ADME-Toxicology Testing Market 2015-2019
About ADME-Toxicology Testing
ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment.
Technavio's analysts forecast the global ADME-toxicology testing market to grow at a CAGR of 10.65% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global ADME-toxicology testing market for the period 2015-2019. To calculate the market size, Technavio analysts consider revenue generated from the sales of products (instruments, assays systems, software solutions, and reagents) used in the following ADME-toxicology testing technologies:In vivo: test performed inside a living organism for drug evaluationIn vitro: test performed in a laboratory (outside of a living cell)This report provides the details about the market in the following there regions: Americas, APAC and EMEA.
Technavio Announces the Publication of its Research Report – Global ADME-Toxicology Testing Market 2015-2019
Technavio recognizes the following companies as the key players in the global ADME-Toxicology testing market: Accelrys (Dassault Systemes), Agilent Technologies, Bio-Rad Laboratories, Promega, Sigma Aldrich and Thermo Fisher Scientific
Other Prominent Vendors in the market are: Cyprtorex, CytoPulse, Entelos, LI-COR Biosciences, Mattek, Miltenyi Biotec, Molecular Toxicology, Quintiles, RTI Health Solutions, SBW, Xenobiotic Detection Systems and Xenometrix
Commenting on the report, an analyst from Technavio’s team said: “The emergence of cell-based assays in the drug development process has enabled drug manufacturers to use the right technology in conducting ADME-toxicology testing and reduce the duration of the drug approval process.”
According to the report, the increase in demand for various toxicology testing procedures from biotechnology and pharmaceutical companies is one of the major drivers of the market. These tests help evaluate the safety profile of a drug, thus reducing the duration of the drug approval process.
Further, the report states that the high cost of the test is a major challenge hindering market growth.
Accelrys (Dassault Systemes), Agilent Technologies, Bio-Rad Laboratories, Promega, Sigma Aldrich, Thermo Fisher Scientific, Cyprtorex, CytoPulse, Entelos, LI-COR Biosciences, Mattek, Miltenyi Biotec, Molecular Toxicology, Quintiles, RTI Health Solutions, SBW, Xenobiotic Detection Systems, Xenometrix
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook